Professor, Department of Pathology, Director of the Toxicology Laboratory, Associate Director of the Clinical Chemistry Lab, University of California, San Diego
BIOGRAPHY
DEC 09, 2015 10:00 AM PST
WEBINAR: Emerging Trends in Heart Failure Therapy and the Importance of Natriuretic Peptides
Speaker
Event Date & Time
Date: December 9, 2015 10AM Pacific, 1PM Eastern
Abstract
July 7, 2015, the U.S. Food and Drug Administration reviewed and approved ENTRESTO™ (sacubitril/valsartan) tablets to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. This important news could shift the paradigm in the way heart failure patients will be managed using NT-proBNP in lieu of BNP for patients receiving ENTRESTO™.
In this webinar, we will discuss the analytical and clinical considerations of NT-proBNP testing and the impact of ENTRESTO™ on biomarker testing.
Learner Objectives:
• Describe differences in stability of NT-proBNP and BNP
• Describe the analytical differences between NT-proBNP and BNP assays
• Describe how natriuretic peptides compare in the setting of renal failure
• Describe the mechanism of action of ENTRESTO™ and it’s effect on natriuretic peptides
In this webinar, we will discuss the analytical and clinical considerations of NT-proBNP testing and the impact of ENTRESTO™ on biomarker testing.
Learner Objectives:
• Describe differences in stability of NT-proBNP and BNP
• Describe the analytical differences between NT-proBNP and BNP assays
• Describe how natriuretic peptides compare in the setting of renal failure
• Describe the mechanism of action of ENTRESTO™ and it’s effect on natriuretic peptides
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
Loading Comments...